Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: Evidence from 35 case-control studies

Molecular Biology Reports

Volumn 39, Issue 2, 2012, Pages 805-816

  Han, Dong ^a   Shen, Chao ^a   Meng, Xiangning ^a   Bai, Jing ^a   Chen, Feng ^a   Yu, Yang ^a   Jin, Yan ^a   Fu, Songbin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cancer risk; Gene polymorphism; Meta analysis; Methionine synthase reductase (MTRR)

Indexed keywords

ADENINE; GUANINE; METHIONINE SYNTHASE REDUCTASE; TUMOR MARKER; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE;

ALLELE; ARTICLE; ASIAN; BLADDER CANCER; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; COLORECTAL CANCER; DOMINANT GENE; ESOPHAGUS CANCER; ETHNICITY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLIOMA; HEAD AND NECK CANCER; HOMOZYGOTE; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; LYMPHATIC LEUKEMIA; LYMPHOMA; MENINGIOMA; MULTIPLE MYELOMA; PANCREAS CANCER; PROSTATE CANCER; RECESSIVE GENE; RISK ASSESSMENT; STATISTICAL ANALYSIS; UTERINE CERVIX CANCER; CELL TRANSFORMATION; DNA METHYLATION; GENETIC PREDISPOSITION; GENETICS; INHERITANCE; META ANALYSIS; NEOPLASM; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; FERREDOXIN-NADP REDUCTASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INHERITANCE PATTERNS; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84860326556     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0802-6     Document Type: Article

References (49)

1. Stern LL, Mason JB, Selhub J, Choi SW (2000) Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 9(8):849-853 (Pubitemid 30660060)
2. Ma J, Stampfer MJ, Christensen B, Giovannucci E, Hunter DJ, Chen J, Willett WC, Selhub J, Hennekens CH, Gravel R, Rozen R (1999) A polymorphism of the methionine synthase gene: asso ciation with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 8(9):825-829 (Pubitemid 29445020)
3. Olteanu H, Munson T, Banerjee R (2002) Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry 41(45):13378-13385 (Pubitemid 35303896)
4. Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yarnell JW, Evans A, Whitehead AS (2001) The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157(2):451-456 (Pubitemid 32710025)
5. Geisel J, Zimbelmann I, Schorr H, Knapp JP, Bodis M, Hubner U, Herrmann W (2001) Genetic defects as important factors for moderate hyperhomocysteinemia. Clin Chem Lab Med 39(8):698-704. doi:10.1515/CCLM.2001.115 (Pubitemid 32894413)
6. O'Leary VB, Parle-McDermott A, Molloy AM, Kirke PN, Johnson Z, Conley M, Scott JM, Mills JL (2002) MTRR and MTHFR polymorphism: link to Down syndrome? Am J Med Genet 107(2):151-155. doi:10.1002/ajmg.10121 (Pubitemid 34038597)
7. Matsuo K, Hamajima N, Hirai T, Kato T, Inoue M, Takezaki T, Tajima K (2002) Methionine synthase reductase gene A66G Polymorphism is associated with risk of colorectal cancer. Asian Pac J Cancer Prev 3(4):353-359
8. Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A (2002) B-vitamin intake, metabolic genes, and colo-rectal cancer risk (United States). Cancer Causes Control 13(3): 239-248 (Pubitemid 34438233)
9. Gast A, Bermejo JL, Flohr T, Stanulla M, Burwinkel B, Schrappe M, Bartram CR, Hemminki K, Kumar R (2007) Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study. Leukemia 21(2):320-325. doi: 10.1038/sj.leu.2404474 (Pubitemid 46158126)
10. Koppen IJ, Hermans FJ, Kaspers GJ (2010) Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia. Br J Haematol 148(1):3-14. doi: 10.1111/j.1365-2141.2009.07898.x
11. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719-748
12. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-188 (Pubitemid 17189972)
13. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315(7109):629-634 (Pubitemid 27387172)
14. Brown CA, McKinney KQ, Kaufman JS, Gravel RA, Rozen R (2000) A common polymorphism in methionine synthase reduc-tase increases risk of premature coronary artery disease. J Cardiovasc Risk 7(3):197-200 (Pubitemid 30463749)
15. Feix A, Winkelmayer WC, Eberle C, Sunder-Plassmann G, Fodinger M (2004) Methionine synthase reductase MTRR 66A[G has no effect on total homocysteine, folate, and Vitamin B12 concentrations in renal transplant patients. Atherosclerosis 174(1):43-48. doi:10.1016/j.atherosclerosis.2003.12.036 (Pubitemid 38595438)
16. Jones PA, Laird PW (1999) Cancer epigenetics comes of age. Nat Genet 21(2):163-167. doi:10.1038/5947 (Pubitemid 29070360)
17. Kwak SY, Kim UK, Cho HJ, Lee HK, Kim HJ, Kim NK, Hwang SG (2008) Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population. Anticancer Res 28(5A):2807-2811
18. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, Ratnasinghe DL, Dawsey SM, Dong ZW, Taylor PR, Mark SD (2003) Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 12(11 Pt 1):1222-1226 (Pubitemid 37499448)
19. Suzuki T, Matsuo K, Hasegawa Y, Hiraki A, Wakai K, Hirose K, Saito T, Sato S, Ueda R, Tajima K (2007) One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cell carcinoma: case-control study. Cancer Sci 98(9):1439-1446. doi:10.1111/j.1349-7006.2007.00533.x (Pubitemid 47241768)
20. Moore LE, Malats N, Rothman N, Real FX, Kogevinas M, Karami S, Garcia-Closas R, Silverman D, Chanock S, Welch R, Tardon A, Serra C, Carrato A, Dosemeci M, Garcia-Closas M (2007) Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer 120(11):2452-2458. doi:10.1002/ijc.22565 (Pubitemid 46642134)
21. Yong D, QingQing W, Hua L, Yang LX, QingLing Z, Ying H, QiaoJing Q, HanChao S (2006) Association of uteroglobin G38A polymorphism with IgA nephropathy: a meta-analysis. Am J Kidney Dis 48(1):1-7. doi:10.1053/j.ajkd. 2006.03.048
22. Koushik A, Kraft P, Fuchs CS, Hankinson SE, Willett WC, Giovannucci EL, Hunter DJ (2006) Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer. Cancer Epidemiol Biomark-ers Prev 15(12):2408-2417. doi:10.1158/1055-9965.EPI-06-0624 (Pubitemid 46048297)
23. Theodoratou E, Farrington SM, Tenesa A, McNeill G, Cetnarskyj R, Barnetson RA, Porteous ME, Dunlop MG, Campbell H (2008) Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 17(1):171-182. doi: 10.1158/1055-9965.EPI-07-0621 (Pubitemid 351196288)
24. Otani T, Iwasaki M, Hanaoka T, Kobayashi M, Ishihara J, Nat-sukawa S, Shaura K, Koizumi Y, Kasuga Y, Yoshimura K, Yoshida T, Tsugane S (2005) Folate, vitamin B6, vitamin B12, and vitamin B2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in Japan. Nutr Cancer 53(1):42-50. doi:10.1207/s15327914nc5301-5 (Pubitemid 43068552)
25. Steck SE, Keku T, Butler LM, Galanko J, Massa B, Millikan RC, Sandler RS (2008) Polymorphisms in methionine synthase, methionine synthase reductase and serine hydroxymethyltrans-ferase, folate and alcohol intake, and colon cancer risk. J Nutri-genet Nutrigenomics 1(4):196-204. doi:10.1159/000136651 (Pubitemid 351873358)
26. Hazra A, Wu K, Kraft P, Fuchs CS, Giovannucci EL, Hunter DJ (2007) Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study. Carcinogenesis 28(7):1510-1519. doi: 10.1093/carcin/bgm062 (Pubitemid 47243540)
27. Kim HN, Kim YK, Lee IK, Yang DH, Lee JJ, Shin MH, Park KS, Choi JS, Park MR, Jo DY, Won JH, Kwak JY, Kim HJ (2009) Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies. Leuk Res 33(1):82-87. doi:10.1016/j.leukres.2008.07.026
28. Gemmati D, Ongaro A, Scapoli GL, Della Porta M, Tognazzo S, Serino ML, Di Bona E, Rodeghiero F, Gilli G, Reverberi R, Caruso A, Pasello M, Pellati A, De Mattei M (2004) Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 13(5):787-794 (Pubitemid 38737868)
29. Petra BG, Janez J, Vita D (2007) Gene-gene interactions in the folate metabolic pathway influence the risk for acute lympho-blastic leukemia in children. Leuk Lymphoma 48(4):786-792. doi:10.1080/10428190601187711 (Pubitemid 46605552)
30. Gra OA, Glotov AS, Kozhekbaeva Z, Makarova OV, Nasedkina TV (2008) Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia. Mol Biol (Mosk) 42(2):214-225
31. de Jonge R, Tissing WJ, Hooijberg JH, Jansen G, Kaspers GJ, Lindemans J, Peters GJ, Pieters R (2009) Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood 113(10):2284-2289. doi:10.1182/blood-2008-07-165928
32. Lissowska J, Gaudet MM, Brinton LA, Chanock SJ, Peplonska B, Welch R, Zatonski W, Szeszenia-Dabrowska N, Park S, Sherman M, Garcia-Closas M (2007) Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int J Cancer 120(12):2696-2703. doi:10.1002/ijc.22604 (Pubitemid 46651293)
33. Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Jin F, Zheng W (2006) MTR and MTRR polymorphisms, dietary intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15(3): 586-588. doi:10.1158/1055-9965.EPI-05-0576
34. Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, Watanabe M, Yamashita T, Iwata H, Tajima K (2008) One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 29(2):356-362. doi:10.1093/carcin/bgm295 (Pubitemid 351359675)
35. Kotsopoulos J, Zhang WW, Zhang S, McCready D, Trudeau M, Zhang P, Sun P, Narod SA (2008) Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res Treat 112(3):585-593. doi: 10.1007/s10549-008-9895-6
36. XuX, GammonMD, ZhangH, WetmurJG, RaoM, Teitelbaum SL, Britton JA, Neugut AI, Santella RM, Chen J (2007) Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis 28(7):1504-1509. doi: 10.1093/carcin/bgm061 (Pubitemid 47241800)
37. Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Khuhaprema T, Yoshida T (2010) Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women. Breast Cancer Res Treat. doi:10.1007/s10549-010-0804-4
38. Rouissi K, Ouerhani S, Oliveira E, Marrakchi R, Cherni L, Ben Othman F, Ben Slama MR, Sfaxi M, Ayed M, Chebil M, Amorim A, Prata MJ, Benammar Elgaaied A (2009) Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population. Cancer Genet Cytogenet 195(1):43-53. doi:10.1016/j.cancergencyto.2009.06.007
39. Kim HN, Kim YK, Lee IK, Lee JJ, Yang DH, Park KS, Choi JS, Park MR, Jo DY, Kim HJ (2007) Polymorphisms involved in the folate metabolizing pathway and risk of multiple myeloma. Am J Hematol 82(9):798-801. doi:10.1002/ajh.20967 (Pubitemid 350194508)
40. Lima CS, Ortega MM, Ozelo MC, Araujo RC, De Souza CA, Lo-rand-Metze I, Annichino-Bizzacchi JM, Costa FF (2008) Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk. Leuk Res 32(3):401-405. doi:10.1016/j.leukres.2007.06.001 (Pubitemid 351295908)
41. Kim HN, Lee IK, Kim YK, Tran HT, Yang DH, Lee JJ, Shin MH, Park KS, Shin MG, Choi JS, Kim HJ (2008) Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol 140(3):287-294. doi:10.1111/j.1365-2141.2007.06893.x
42. Zhang FF, Terry MB, Hou L, Chen J, Lissowska J, Yeager M, Zatonski W, Chanock S, Morabia A, Chow WH (2007) Genetic polymorphisms in folate metabolism and the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev 16(1):115-121. doi: 10.1158/1055-9965.EPI-06-0513 (Pubitemid 46174273)
43. Zhang Z, Shi Q, Liu Z, Sturgis EM, Spitz MR, Wei Q (2005) Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Cancer Epidemiol Biomarkers Prev 14(5):1188-1193. doi:10.1158/1055-9965.EPI-04-0501 (Pubitemid 40656465)
44. Suzuki T, Matsuo K, Hiraki A, Saito T, Sato S, Yatabe Y, Mitsudomi T, Hida T, Ueda R, Tajima K (2007) Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study. Carcinogenesis 28(8): 1718-1725. doi:10.1093/carcin/bgm104 (Pubitemid 47303945)
45. Shi Q, Zhang Z, Li G, Pillow PC, Hernandez LM, Spitz MR, Wei Q (2005) Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case-control analysis. Pharmacogenet Genomics 15(8):547-555 (Pubitemid 41044240)
46. Bethke L, Webb E, Murray A, Schoemaker M, Feychting M, Lonn S, Ahlbom A, Malmer B, Henriksson R, Auvinen A, Kiuru A, Salminen T, Johansen C, Christensen HC, Muir K, McKinney P, Hepworth S, Dimitropoulou P, Lophatananon A, Swerdlow A, Houlston R (2008) Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev 17(5):1195-1202. doi:10.1158/1055-9965.EPI-07-2733
47. Suzuki T, Matsuo K, Sawaki A, Mizuno N, Hiraki A, Kawase T, Watanabe M, Nakamura T, Yamao K, Tajima K, Tanaka H (2008) Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 17(10):2742-2747. doi:10.1158/1055-9965. EPI-08-0470
48. Marchal C, Redondo M, Reyes-Engel A, Perea-Milla E, Gaitan MJ, Machuca J, Diaz F, Caballero J, Carnero J (2008) Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer. Eur J Surg Oncol 34(7):805-810. doi: 10.1016/j.ejso.2007.09.008 (Pubitemid 351818235)
49. Tong SY, Lee JM, Song ES, Lee KB, Kim MK, Yun YM, Lee JK, Son SK, Lee JP, Kim JH, Hur SY, Kwon YI (2010) The effects of polymorphisms in methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), and methionine synthase reductase (MTRR) on the risk of cervical intraepithelial neoplasia and cervical cancer in Korean women. Cancer Causes Control 21(1): 23-30. doi:10.1007/s10552-009-9430-z